Ginkgo Bioworks Holdings, Inc. (DNA) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Ginkgo Bioworks Holdings, Inc. (DNA) closed at USD 11.53 on 2026-10-14, a change of -9.5 % over the past year, with a market capitalization of USD 791.92M.

Ginkgo Bioworks Holdings, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Ginkgo Bioworks Holdings, Inc. key figures

Previous close

USD 11.53 (2026-10-14)

1-year change

-9.5 %

Market cap

USD 791.92M

Enterprise value

USD 893.87M

P/E ratio (trailing)

-2.32

P/E ratio (forward)

-4.06

EPS (trailing)

-5.06

EPS (forward)

-2.90

PEG ratio

n/a

Price to book

1.78

Revenue growth

-48.5 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

3.90

Employees

485

Analyst consensus (third-party)

underperform

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Ginkgo Bioworks Holdings, Inc. and compare it with other stocks.